Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zivelin

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|July 1, 1997
Thrombophilia as a multigenic disorderU Seligsohn, A Zivelin
Thrombosis and Haemostasis|June 30, 1976
Fibrinogen response to turpentine and endotoxin in busulfan-treated rabbbitsS I Rapaport, A Zivelin
Thrombosis Research|January 1, 1984
Decreased factor VIII clotting antigen levels in the combined factor V and VIII deficiencyU Seligsohn, A Zivelin, E Zwang
Thrombosis Et Diathesis Haemorrhagica|February 28, 1973
Patterns of incorporation of 75 Se-methionine into fibrinogen and other plasma proteins in rabbits stimulated by different test conditionsU Seligsohn, S I Rapaport, A Zivelin
The New England Journal of Medicine|November 4, 1982
Combined factor V and factor VIII deficiency among non-Ashkenazi JewsU Seligsohn, A Zivelin, E Zwang
American Journal of Clinical Pathology|April 1, 1987
A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency statesS I Rapaport, A Zivelin, K Donnelly
Haemostasis|January 1, 1983
Cold-promoted activation of factor VII: is It a problem under blood bank conditions?U Seligsohn, A Zivelin, S Bar-Shani
Thrombosis and Haemostasis|February 28, 1989
The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in IsraelO Ben-Tal, A Zivelin, U Seligsohn
The American Journal of Physiology|May 1, 1975
Fibrinogen levels after inflammation or endotoxin in normal and hypophysectomized ratsS H Goodnight, S I Rapaport, A Zivelin
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2008
Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasmaT Livnat, U Martinowitz, A Zivelin, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|July 1, 1997
Thrombophilia as a multigenic disorderU Seligsohn, A Zivelin
Thrombosis and Haemostasis|June 30, 1976
Fibrinogen response to turpentine and endotoxin in busulfan-treated rabbbitsS I Rapaport, A Zivelin
Thrombosis Research|January 1, 1984
Decreased factor VIII clotting antigen levels in the combined factor V and VIII deficiencyU Seligsohn, A Zivelin, E Zwang
Thrombosis Et Diathesis Haemorrhagica|February 28, 1973
Patterns of incorporation of 75 Se-methionine into fibrinogen and other plasma proteins in rabbits stimulated by different test conditionsU Seligsohn, S I Rapaport, A Zivelin
The New England Journal of Medicine|November 4, 1982
Combined factor V and factor VIII deficiency among non-Ashkenazi JewsU Seligsohn, A Zivelin, E Zwang
American Journal of Clinical Pathology|April 1, 1987
A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency statesS I Rapaport, A Zivelin, K Donnelly
Haemostasis|January 1, 1983
Cold-promoted activation of factor VII: is It a problem under blood bank conditions?U Seligsohn, A Zivelin, S Bar-Shani
Thrombosis and Haemostasis|February 28, 1989
The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in IsraelO Ben-Tal, A Zivelin, U Seligsohn
The American Journal of Physiology|May 1, 1975
Fibrinogen levels after inflammation or endotoxin in normal and hypophysectomized ratsS H Goodnight, S I Rapaport, A Zivelin
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2008
Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasmaT Livnat, U Martinowitz, A Zivelin, et al.
Pageof 8